Lupin Limited

BSE : 500257 | NSE : LUPIN
Industry : Pharma Drugs | ISIN : INE326A01037 | FreeFloat : 55.00% | FnO : Yes | LotSize : 700
Intellectual Capital (IC)-5,701.97
Net Worth (NW)13,745.95
Intrinsic Worth (IW)8,043.98
Market Cap (MC)34,577.17
Economic Value Added-608.11
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)-70.88%
IC Gross Margin (EBITDA/IC)-37.95%
IC Net Margin (NPT/IC)6.70%
Knowledge Turnover (Sales/IC)-2.91
Market to Intrinsic Value (MC/IW)4.30
As OfIntrinsic ValueMarket Price
31 Dec 2019Rs. 177.61Rs. 763.45
26 May 2020 - Rs. 905.95
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 865.08BuyHold
KB > 50% : No50 DMA : Rs. 750.62
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-17
C
4253.30
4298.64
826.71
559.29
518.67
381.99
380.21
Jun-17
C
3805.83
3869.58
798.07
537.56
493.66
356.85
365.53
Sep-17
C
3951.96
4026.00
931.03
658.85
610.93
456.87
442.62
Dec-17
C
3975.62
4004.04
717.35
437.00
383.00
222.23
195.89
Mar-18
C
4033.83
4178.75
-662.10
-934.93
-940.78
-777.60
-783.54
Jun-18
C
3855.93
4040.13
711.86
452.88
384.16
203.02
-67.47
Sep-18
C
3951.06
4181.74
780.67
515.18
441.36
268.45
242.73
Dec-18
C
4504.85
4548.29
454.97
175.21
95.44
-152.36
-130.06
Mar-19
C
4406.32
4492.82
962.51
681.73
596.21
296.37
336.59
Jun-19
C
4418.38
4490.59
933.42
616.33
530.71
303.05
377.60
Sep-19
C
4359.55
4492.92
318.79
-2.68
-89.14
-127.07
-214.23
Dec-19
C
3716.09
3769.27
235.01
-18.22
-106.82
-835.00
-891.98
* C - Consolidated, S - Standalone